Angiopoietins modulate endothelial adaptation, glomerular and podocyte hypertrophy after uninephrectomy

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Chiang, Wen Chih ^a   Lai, Chun Fu ^a   Su, Chi Ting ^a   Peng, Wei Hao ^b   Wu, Ching Fang ^a   Chang, Fan Chi ^a   Chen, Yi Ting ^c   Lin, Shuei Liong ^a,b   Chen, Yung Ming ^a   Wu, Kwan Dun ^a   Lu, Kuo Shyan ^b   Tsai, Tun Jun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c E DA HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 1 BLOKING AGENT; ANGIOPOIETIN 2; ANGIOPOIETIN 2 BLOCKING AGENT; ANGIOPOIETIN RECEPTOR; CD31 ANTIGEN; COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA1 CHAIN; COLLAGEN TYPE 4 ALPHA2 CHAIN; COLLAGEN TYPE 4 ALPHA5; CREATININE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR HOMOLOGY DOMAIN 2; IMMUNOGLOBULIN; LAMININ ALPHA5; MEMBRANE PROTEIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ADAPTATION; ANGPT1 GENE; ANGPT2 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL DENSITY; COLLAGEN TYPE 4 ALPHA1 GENE; COLLAGEN TYPE 4 ALPHA2 GENE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DOWN REGULATION; ENDOTHELIAL ADAPTATION; ENZYME ACTIVATION; FOOT; GENE; GENE EXPRESSION; GENE SYNTHESIS; GLOMERULAR VOLUME; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; GROWTH INHIBITION; HYPERTROPHY; KIDNEY EXAMINATION; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; KIDNEY MASS; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PODOCYTE; PODOCYTE HYPERTROPHY; PROTEIN FUNCTION; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; THICKNESS; UNINEPHRECTOMY;

ANGIOPOIETIN-1; ANGIOPOIETINS; ANIMALS; BLOTTING, WESTERN; FLUORESCENT ANTIBODY TECHNIQUE; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; MALE; MICE; MICE, INBRED BALB C; NEPHRECTOMY; PODOCYTES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84893181875     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082592     Document Type: Article

References (41)

1. Nyengaard JR (1993) Number and dimensions of rat glomerular capillaries in normal development and after nephrectomy. Kidney Int 43: 1049-1057.
2. Nyengaard JR, Rasch R (1993) The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia 36: 189-194.
3. Marcussen N, Nyengaard JR, Christensen S (1994) Compensatory growth of glomeruli is accomplished by an increased number of glomerular capillaries. Laboratory investigation; a journal of technical methods and pathology 70: 868-874.
4. Flyvbjerg A, Schrijvers BF, De Vriese AS, Tilton RG, Rasch R (2002) Compensatory glomerular growth after unilateral nephrectomy is VEGF dependent. American journal of physiology Endocrinology and metabolism 283: E362-366.
5. Schrijvers BF, Flyvbjerg A, Tilton RG, Lameire NH, De Vriese AS (2006) A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 21: 324-329.
6. Schrijvers BF, Rasch R, Tilton RG, Flyvbjerg A (2002) High protein-induced glomerular hypertrophy is vascular endothelial growth factor-dependent. Kidney international 61: 1600-1604.
7. Morisada T, Kubota Y, Urano T, Suda T, Oike Y (2006) Angiopoietins and angiopoietin-like proteins in angiogenesis. Endothelium : journal of endothelial cell research 13: 71-79.
8. Lobov IB, Brooks PC, Lang RA (2002) Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proceedings of the National Academy of Sciences of the United States of America 99: 11205-11210.
9. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60.
10. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, et al. (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87: 1171-1180.
11. Campean V, Karpe B, Haas C, Atalla A, Peters H, et al. (2008) Angiopoietin 1 and 2 gene and protein expression is differentially regulated in acute anti-Thy1.1 glomerulonephritis. Am J Physiol Renal Physiol 294: F1174-1184.
12. Woolf AS, Yuan HT (2001) Angiopoietin growth factors and Tie receptor tyrosine kinases in renal vascular development. Pediatr Nephrol 16: 177-184.
13. Yuan HT, Suri C, Yancopoulos GD, Woolf AS (1999) Expression of angiopoietin-1, angiopoietin-2, and the Tie-2 receptor tyrosine kinase during mouse kidney maturation. J Am Soc Nephrol 10: 1722-1736.
14. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, et al. (1999) Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284: 1994-1998.
15. Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, et al. (1994) Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8: 1897-1909.
16. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, et al. (2000) Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6: 460-463.
17. Yuan HT, Suri C, Yancopoulos GD, Woolf AS (1999) Expression of angiopoietin-1, angiopoietin-2, and the Tie-2 receptor tyrosine kinase during mouse kidney maturation. Journal of the American Society of Nephrology : JASN 10: 1722-1736.
18. Jeansson M, Gawlik A, Anderson G, Li C, Kerjaschki D, et al. (2011) Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. The Journal of clinical investigation 121: 2278-2289.
19. Falcon BL, Hashizume H, Koumoutsakos P, Chou J, Bready JV, et al. (2009) Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels. The American journal of pathology 175: 2159-2170.
20. Reinhardt C, Bergentall M, Greiner TU, Schaffner F, Ostergren-Lunden G, et al. (2012) Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling. Nature 483: 627-631.
21. Coxon A, Bready J, Min H, Kaufman S, Leal J, et al. (2010) Context-dependent role of angiopoietin-1 inhibition in the suppression of angiogenesis and tumor growth: implications for AMG 386, an angiopoietin-1/2- neutralizing peptibody. Mol Cancer Ther 9: 2641-2651.
22. Tressel SL, Kim H, Ni CW, Chang K, Velasquez-Castano JC, et al. (2008) Angiopoietin-2 stimulates blood flow recovery after femoral artery occlusion by inducing inflammation and arteriogenesis. Arterioscler Thromb Vasc Biol 28: 1989-1995.
23. Mundel P, Reiser J, Zuniga Mejia Borja A, Pavenstadt H, Davidson GR, et al. (1997) Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Experimental cell research 236: 248-258.
24. Weibel ER (1979) Stereological Methods: Practical Methods for Biological Morphometiy. London: Academic Press. 51-57 p.
25. Schrijvers BF, Flyvbjerg A, Tilton RG, Rasch R, Lameire NH, et al. (2005) Pathophysiological role of vascular endothelial growth factor in the remnant kidney. Nephron Experimental nephrology 101: e9-15.
26. Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, et al. (2008) VEGF inhibition and renal thrombotic microangiopathy. The New England journal of medicine 358: 1129-1136.
27. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, et al. (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87: 1161-1169.
28. Holash J, Wiegand SJ, Yancopoulos GD (1999) New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18: 5356-5362.
29. Kim KE, Cho CH, Kim HZ, Baluk P, McDonald DM, et al. (2007) In vivo actions of angiopoietins on quiescent and remodeling blood and lymphatic vessels in mouse airways and skin. Arterioscler Thromb Vasc Biol 27: 564-570.
30. Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, et al. (2002) Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 3: 411-423.
31. Kim I, Kim JH, Moon SO, Kwak HJ, Kim NG, et al. (2000) Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Oncogene 19: 4549-4552.
32. Bogdanovic E, Nguyen VP, Dumont DJ (2006) Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization. J Cell Sci 119: 3551-3560.
33. Korff T, Kimmina S, Martiny-Baron G, Augustin HG (2001) Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J 15: 447-457.
34. Teichert-Kuliszewska K, Maisonpierre PC, Jones N, Campbell AI, Master Z, et al. (2001) Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res 49: 659-670.
35. Yuan HT, Khankin EV, Karumanchi SA, Parikh SM (2009) Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol 29: 2011-2022.
36. Miner JH (1998) Developmental biology of glomerular basement membrane components. Curr Opin Nephrol Hypertens 7: 13-19.
37. Abrahamson DR, Hudson BG, Stroganova L, Borza DB, St John PL (2009) Cellular origins of type IV collagen networks in developing glomeruli. J Am Soc Nephrol 20: 1471-1479.
38. St John PL, Abrahamson DR (2001) Glomerular endothelial cells and podocytes jointly synthesize laminin-1 and -11 chains. Kidney Int 60: 1037-1046.
39. Miner JH (1999) Renal basement membrane components. Kidney international 56: 2016-2024.
40. Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, et al. (2003) Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. The Journal of biological chemistry 278: 12605-12608.
41. Henao DE, Saleem MA, Cadavid AP (2010) Glomerular disturbances in preeclampsia: disruption between glomerular endothelium and podocyte symbiosis. Hypertens Pregnancy 29: 10-20.